Pharmafile Logo

Webinar: The patient journey: Time to look beyond the physician?

March 31, 2015 | Patient journey, webinar 

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

However a recent study demonstrated that physicians spend as little as 49 seconds in dealing with a new treatment initiation with their patients.

So it is no surprise that more and more pharma marketers are steadily looking beyond the physician in order to improve patient engagement.

Pharma companies are increasingly looking at “beyond the pill” strategies in order to gain greater patient engagement and to differentiate themselves in a crowded market. And so now more than ever, the researcher needs to ensure that they have a full understanding of the patient journey in order to sufficiently support their services strategy.

In this webinar Director Katrina Johnson and Associate Director Kate Hanson explore the ways that patient journey research can aid development of an effective “beyond the pill” strategy, leading to greater patient engagement and improved treatment outcomes. 

Gain answers to your key questions:

  • Learn how to overcome pitfalls associated in marketing to a non-DTC market
  • Identify the opportunities and challenges along the journey that affect patient engagement
  • Gain a deeper understanding of how the patient journey can provide pharma with a point of differentiation in a crowded market

To view this webinar please visit http://bit.ly/1y8lj3Y

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.